Article: PAKISTAN HAS ENORMOUS POTENTIAL IN CLINICAL TRIAL BUSINESS.

KARACHI, May 1 Asia Pulse - Pakistan has the potential to earn $US50-100 million in the pharmaceuitical industry clinical trial business in the next three years as well as generating major employment in this area.

Tariq Ikram, Chief Executive Officer (CEO) of Trade Development Authority of Pakistan (TDAP)made the announcement while speaking at a seminar on 'Clinical Research Management in Pakistan' on Saturday.

Mr Ikram said "the clinical trial business is a new area, enormous potential exists in the country for which concerted efforts are needed to tap this potential."

The seminar was organised jointly by TDAP and Ministry of Health.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!